Percutaneous injuries in the dental office are one of the main risk factors for the transmission of diseases like hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV). HBV is an important infectious disease that is to be focused on in a dental setting. According to Centers for Disease Control and Prevention (CDC), dental work ranks first in the frequency of potential sources for acquiring viral hepatitis, while dental employment ranks eleventh. It is necessary that all dental practitioners are aware of the post-exposure prophylaxis (PEP) to be followed in case of exposure to HBV, HCV or HIV and the protocol followed in situations of exposure and that adequate reporting of the situation is performed. The protocol discussed is to be displayed in all dental settings so that every dental personnel will be aware of the necessary prophylaxis to be followed in any case of accidental exposure to infected source.
THE PRESENT SCENARIO
Percutaneous injuries in the dental office are one of the main risk factors for the transmission of diseases, like hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV). 1, 2 HBV is an important infectious disease that is to be focused on in a dental setting. According to Centers for Disease Control and Prevention (CDC), dental work ranks first in the frequency of potential sources for acquiring viral hepatitis, while dental employment ranks eleventh. 3 A study by Ilguy D et al has reported that 0.8% of the patients in a dental facility were HBV carriers and 17% of the patients did not know what type of hepatitis they suffered from. They concluded that this poses a risk of transmission in the dental office, so strict sterilization procedures should be adhered to. 4 In a study done in Vancouver, 11% of dental professionals had HBV infection and the infection rate was 18% higher among dentists than other dental professionals. 5 Another study done among Egyptian dentists showed that dentists had an exposure rate of 27.1% with a carrier rate of 7.1% for HBV. 6 Comparing general dentists and oral surgeons in the United States showed presence of serological markers of HBV infection in 7.8% of general dentists and 21.2% in oral surgeons. 7 A study among dentists in Berlin showed that 7% of dentists had evidence of previous infection with HBV and HCV and only 74% had been vaccinated against HBV. 8 Among doctors and dentists in Ibadan, Nigeria, a high prevalence of HBV was reported with a high potential for transmissibility. 9 A study in Brazil showed that seropositivity for HBV infection was high among dentists. 10 Another study among dentists in Khartoum, Sudan showed that only 52% of the dentists had undertaken HBV vaccination.
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Vaccination against HBV was reported as 62% among dentists in Haryana, India. 12 There have also been evidence of the presence of HBV DNA in saliva of infected individuals, which maybe a potential route of horizontal transmission of the disease. [13] [14] [15] The risk of transmission of HBV varies between 37 and 62% if the HBsAg and HBeAg are both positive, while the risk is lower (23-37%) if the carrier is positive only for HBsAg. 16 Risk of transmission of hepatitis C ranges between 0 and 7%. 16 HIV and AIDS are on the rise in the present day. Although the risk of HIV transmission in the dental office is very low, 17, 18 there have been reports of transmission of HIV from patient, 19 and seroconversion of dental care professionals. 20 Studies done on the risk of HIV infection among health care professionals have reported that the average risk is 0.3% on percutaneous injury 21 and 0.1% on exposure of mucous membranes in the eye, mouth or nose. 22 The transmission of HIV can be significantly reduced by the use of appropriate infection control procedures, safety needles and safety equipment. 23 A study among HIV individuals on self-disclosure of HIV status to dentists reported that only 53% revealed their HIV status.
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THE FIRST STEP: SELF PROTECTION
Self protection of the dental professional can be inculcated by ensuring thorough washing of hands prior to and after patient care. Use of personal protective equipment, such as gloves, masks, aprons and safe handling and disposal of needles are essential for prevention of infection. In case of accidental spill of body fluids, pour disinfectant (1% sodium hypochlorite) over the spill, and mop up using gloves with an absorbent material after a contact period of 30 minutes. The gloves and the mop are then disinfected and hands washed thoroughly.
Vaccination against HBV is to be taken by every dental professional. It is administered as three doses. It is advisable to check the antibody levels a month after the third dose. The protective level of antibodies is 10 IU/L or more.
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WHAT TO DO IMMEDIATELY IN CASE OF OCCUPATIONAL EXPOSURE
Immediately following an exposure:
• Needle stick injuries and cuts should be washed with soap and water • Pricked finger should not be put into mouth reflexively • Splashes to the nose, mouth or skin should be flushed with plenty of water • Eyes should be irrigated with clean water or saline.
There is no need for local antiseptics or disinfectants as they have not been known to reduce the transmission of the virus, but they have not been contraindicated.
REPORTING AND DOCUMENTATION
Reporting the exposure to the appropriate authority is essential, and the post-exposure prophylaxis should be started as soon as possible. The infection control officer or authorized medical attendant (AMA) should record the circumstances, details of the injury, ordering baseline investigations based on exposure and also to provide counseling. Then the AMA will begin the postexposure prophylaxis (PEP) in consultation with a physician.
The following are to be recorded in the exposed person's confidential medical record:
• Date and time of exposure • Details of the procedure being performed, including where and how the exposure occurred; if related to a sharp device • Details of the exposure, including the type and amount of fluid or material and the severity of the exposure (e.g. for a percutaneous exposure, depth of injury and whether fluid was injected; for a skin or mucous membrane exposure, the estimated volume of material and the condition of the skin, such as chapped, abraded, intact) • Details about the exposure source (e.g. whether the source material contained HBV, HCV or HIV; if the source is HIVinfected, the stage of disease, history of antiretroviral therapy, viral load and antiretroviral resistance information, if known) • Details about the exposed person (e.g. hepatitis B
vaccination and vaccine-response status); and • Details about counseling, post-exposure management, and follow-up.
Evaluation of the Exposure
In order to administer the appropriate prophylaxis, it is necessary to assess type of occupational exposure. The factors to be considered are given in Table 1 . The dental professional should be assessed for baseline status in terms of HBsAg, anti-HCV and anti-HIV within 72 hours of injury. In case of exposure to HBV, the vaccination status and antibody response should be assessed.
Evaluation of the Source
The person whose blood or body fluid was the source of exposure should be evaluated for infection with HBV, HIV or HCV. Information from the medical record at the time of exposure or from the source person may confirm or exclude the presence of infection. If the infection status of the source is unknown, the person should be informed of the incident and tested for the presence of infection. Testing to determine HBV, HCV, HIV should be done as soon as possible (24-48 hours). 25 On serologic testing, if HBsAg is positive, then HBeAg has to be assessed. If the anti HCV is positive, then HCV viral load is to be assessed. If the HIV antibody is positive, then CD4 count, HIV-1 load, history of antiretroviral therapy and stage of clinical disease has to be assessed (Table 2) . 27 If the source individual cannot be tested or identified, then information on the circumstances of exposure should be assessed based on the details of the medical history, clinical symptoms and history or likelihood of high-risk exposure (Table 3) . The guidelines for HIV PEP depend on the source of exposure and the status of the source. 16, 27 The flowchart to determine the source of exposure and status of the source are presented in Figures 1 and 2 . Table 3 classifies the type of PEP recommended based on the exposure and status of source.
Post-Exposure Prophylaxis: What Every Dental Personnel Should Know
WJD
POSTEXPOSURE PROPHYLAXIS
PEP for exposure to HBV, HCV and HIV have to be started as soon as possible after the incident, preferably within 1-2 hours. 16, 26 HBV PEP for HBV should be given as soon as possible (possibly within 24 hours) and at least within 7 days of exposure as given in Table 4 . 
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HIV PEP for HIV exposure should start within the next hour after the exposure. Expert consultation is to be sought if the delay is more than 36 hours. Once the PEP is started it should continue for a period of 28 days. A two drug regimen is used for lowrisk exposures and a three drug regimen is used for exposures with increased risk of transmission. When PEP is initiated, a baseline investigation of serum creatinine, liver function tests with enzymes and complete blood counts is to be completed. The following are recommendations regarding HIV postexposure prophylaxis: 27 • If indicated, start PEP as soon as possible after an exposure.
Reevaluation of the exposed person should be considered within 72 hours post-exposure, especially as additional information about the exposure or source person becomes available.
• Administer PEP for 4 weeks, if tolerated.
• If a source person is determined to be HIV-negative, PEP should be discontinued.
FOLLOW-UP OF EXPOSED DENTAL PERSONNEL 16
HBV:
The dental personnel should be tested for HBsAg at intervals of 6 weeks, 3 and 6 months. If the vaccination had already been undertaken, then tests to determine presence of anti-HBs antibodies should be determined. If HBIG has been given 3 to 4 months prior to the incident, then anti-HBs cannot be determined.
HCV:
Tests for anti-HCV and ALT are done at intervals of 4 to 6 weeks and then repeated at 4 to 6 months. If the tests are positive repeatedly, then supplemental HCV testing, like recombinant immunoblot assay (RIBA) should be done. HCV RNA can be performed at 4 to 6 weeks for early diagnosis of infection.
HIV: HIV antibody should be tested for at intervals of 6 weeks, 3 and 6 months. HIV antibody testing with enzyme immunosorbent assay (EIA) should be done to monitor for seroconversion.
CONCLUSION
Due to the nature of dental treatment and dental work, it is necessary that all dental practitioners are aware of the PEP to be followed in case of exposure to HBV, HCV or HIV and the protocol followed in situations of exposure and that adequate reporting of the situation is performed. The protocol is to be displayed in all dental settings so that every dental personnel will be aware of the necessary prophylaxis to be followed in any case of accidental exposure to infected source.
